Lazard Asset Management LLC Simulations Plus, Inc. Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$33.36 - $45.71 $64,151 - $87,900	1,923 Added 102.12%	3,806 $170,000
Q3 2023 Nov 14, 2023	BUY	$40.03 - $51.51 $7,565 - $9,735	189 Added 11.16%	1,883 $78,000
Q4 2022 Feb 14, 2023	BUY	$36.55 - $51.15 $61,915 - $86,648	1,694 New	1,694 $61,000
Q4 2020 Feb 11, 2021	SELL	$53.26 - $77.18 $17 Million - $24.6 Million	-318,727 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$57.51 - $75.36 $18.3 Million - $24 Million	318,727 New	318,727 $24 Million

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.